Skip to main content
Equibles
STAA logo

STAA · Staar Surgical Co

Track STAA — free

Use STAA with AI

Ask our own analyst here, or connect this data to the AI you already use.

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

ChatGPT Claude Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$23.47 -0.11 (-0.45%) At close · Sep 4
S&P 600 member Russell 2000 member Rebalance outlook locked
Market Cap
$1.18B
Shares
50.14M

STAA metrics

67 of 114 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$23.47
Market cap
$1.18B

Price action

19 metrics
Price change (1W)
+6.2%
Price change (30D)
+1.5%
Price change (3M)
-21.7%
Price change (6M)
+27.1%
Price change (YTD)
+1.6%
Price change (1Y)
-15.5%
Trailing year
Price change (5Y)
-85.0%
52-week high
$33.34
52-week low
$16.10
Change from 52-week high
-29.6%
Change from 52-week low
+45.8%
Annualized volatility
54.8%
Beta
0.4
RSI (14D)
46.7
Price vs SMA 50
-6.4%
Price vs SMA 200
-2.4%
Avg volume (3M)
857,606
Relative volume
2.3
Average dollar volume
$21.97M

Company

3 metrics
Sector
Healthcare
Industry
Medical Instruments & Supplies
Shares outstanding
50.14M

Valuation

12 metrics
P / E (TTM)
293.4
Trailing earnings · reciprocal yield 0.3%
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
3.5×
reciprocal yield 28.7%
P / book
3.2
reciprocal yield 30.9%
FCF yield
-0.6%
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
0.3%

Historical valuation

8 metrics
P / E historical average (3Y)
133.7×
reciprocal yield 0.7%
P / E historical average (5Y)
129.8×
reciprocal yield 0.8%
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-08-12

Profitability

9 metrics
Gross margin
76.6%
Operating margin
4.0%
Trailing 12 months
Net margin
1.1%
Gross profit (TTM)
$260.20M
Operating profit (TTM)
$13.73M
Net income (TTM)
$3.84M
Trailing 12 months
Diluted EPS (TTM)
$0.08
FCF margin
-2.0%
Effective tax rate
77.9%

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
$7.08

Growth

11 metrics
Revenue growth YoY
+111.0%
Year over year
Net income growth YoY
—
Revenue (TTM)
$339.59M
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+4.0%
Year over year · more shares
Revenue CAGR (3Y)
+0.0%
Revenue CAGR (5Y)
+7.9%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
1.1%
Return on assets
0.8%
Debt / equity
—
Current ratio
4.7
EBITDA (TTM)
—
Free cash flow (TTM)
−$6.75M
Quick ratio
—
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
$181.49M
Latest balance sheet
Cash & equivalents
$148.58M
Total assets
$475.20M
Total debt
—

Cash flow & spend

7 metrics
Operating cash flow (TTM)
−$3.25M
Capital expenditures (TTM)
$3.50M
R&D (TTM)
$38.32M
SG&A (TTM)
$246.47M
Stock compensation (TTM)
$28.15M
R&D / revenue
11.3%
Stock compensation / revenue
8.3%

Ownership (13F)

3 metrics
13F filers
201
13F filer change QoQ
+14
Institutional ownership
111.3%

Short interest

3 metrics
Short interest
8.8%
Latest settlement · 4.0 days to cover
Days to cover
4.0d
Short-squeeze score
66 / 100

Insider activity

2 metrics
Net insider buying (90D)
—
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
—
Key facts CIK 718937 CUSIP 852312305 13F (30d) 161 filings 154 filers Visit website Investor relations